Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment

NCT02555527 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500000

Last updated 2017-05-04

No results posted yet for this study

Summary

To perform a cost-effectiveness analysis for the routine use of contrast in rest echocardiography in patients with dilated or ischemic cardiomyopathy from the United States healthcare system, provider and payer perspectives.

Conditions

  • Cardiomyopathies

Sponsors & Collaborators

Principal Investigators

  • Pamela S Douglas, MD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-12-31
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02555527 on ClinicalTrials.gov